Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2019-04-30 Management Reports
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Sprawozdanie Zarządu GRUPA BIOTON 2018
Management Reports Classification · 95% confidence The document is titled 'Sprawozdanie Zarządu BIOTON S.A. z działalności Grupy Kapitałowej' (Management Board Report of BIOTON S.A. on the activities of the Capital Group) for the period 01.01.2018 to 31.12.2018. It contains a detailed table of contents covering financial statements, organizational structure, economic-financial analysis, risk factors, legal proceedings, and investment activities. This is a comprehensive annual management report that accompanies the annual financial statements, which falls under the category of Management Reports (MDA). FY 2018
2019-04-30 Polish
Sprawozdanie niezależnego biegłego rewidenta GRUPA BIOTON 2018
Audit Report / Information Classification · 100% confidence The document is titled "Sprawozdanie niezależnego biegłego rewidenta z badania" (Independent Auditor's Report on the Audit) and specifically mentions the audit of the "rocznego skonsolidowanego sprawozdania finansowego" (annual consolidated financial statements) for the year ended December 31, 2018. It contains the auditor's opinion, basis for opinion, scope of the audit, and details key audit matters, which are hallmarks of an Audit Report. Although it relates to the annual financial statements, the document itself is the formal opinion provided by the external auditor, which aligns best with the 'Audit Report / Information' category (AR), rather than the 'Annual Report' (10-K) which is the primary filing by the company containing the statements themselves. Given the explicit focus on the auditor's opinion and procedures, AR is the most precise classification. FY 2018
2019-04-30 Polish
Skonsolidowane Sprawozdanie Finansowe GRUPA BIOTON 2018
Annual Report Classification · 100% confidence The document is a comprehensive consolidated financial report for the fiscal year ending December 31, 2018, prepared in accordance with IFRS. It includes a table of contents, consolidated financial statements (balance sheet, income statement, cash flow, etc.), and detailed explanatory notes. It is not an announcement or a summary, but the full annual financial report. In the context of the provided categories, a full annual financial report is classified as a 10-K (Annual Report). FY 2018
2019-04-30 Polish
Pismo Zarządu
Management Reports Classification · 95% confidence The document is a letter from the Management Board of BIOTON S.A. to shareholders, dated April 30, 2019. It provides a detailed narrative review of the company's 2018 financial performance, strategic transformation, operational highlights, and specific explanations regarding accounting adjustments (MSSF 15 and intangible asset corrections). While it references financial statements, it functions as the management's commentary and analysis of the business trends and results for the fiscal year, which aligns with the definition of a Management Report (MDA). FY 2018
2019-04-30 Polish
Informacja o wstępnych szacunkach wyników finansowych dokonanych w toku prac nad raportem okresowym. - Content (PL)
Audit Report / Information Classification · 99% confidence The document is a formal announcement by the management board of Bioton S.A. regarding a significant accounting adjustment concerning revenue recognition for license payments, based on a reservation made by the external auditor (PricewaterhouseCoopers) in their review report for the 2018 interim financial statements. The text details the financial impact (reduction in 2018 revenue, creation of deferred revenue, non-cash impact) and states that the final consolidated and individual financial reports for 2018 will be published on April 30, 2019. Since this document is an announcement *about* the financial statements and the necessary adjustments, and it explicitly states the publication date of the actual report, it fits the definition of a Report Publication Announcement (RPA). It is not the full financial report (10-K or IR) itself, nor is it a general earnings release (ER) or a management discussion (MDA), but rather a specific notice about the impending release of the audited reports following an accounting dispute. FY 2018
2019-04-29 Polish
Rezygnacja osoby zarządzającej BIOTON S.A. - Content (PL)
Board/Management Information Classification · 98% confidence The document text is very short (344 characters) and announces the immediate resignation of Mr. Bogusław Kociński from the Management Board ('Członka Zarządu Spółki'). This directly relates to a change in senior management personnel. Based on the definitions, this aligns perfectly with the Board/Management Information category.
2019-04-26 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.